Clinical Trial Update: Dexmedetomidine in Different Dose Levels as Adjuvant to Bupivacaine-induced Ultrasound-guided Femoral Nerve Block. [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating dexmedetomidine at different dose levels as an adjuvant to bupivacaine in ultrasound-guided femoral nerve block for knee surge…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Arthroscopic Knee Surgery
• Femoral Nerve Block-related Pain

Drugs mentioned

• Bupivacaine (Bupivacaine)
• Dexmedetomidine (Dexmedetomidine)

Snippet

Sponsor: Cairo University | Conditions: Dexmedetomidine, Femoral Nerve Block | Phase 4 | Status: COMPLETED